Please see the link below to our first of many departmental newsletters.
The symposium was held in the Trinity Translational Medicine Institute at St. James’s Hospital.The prize was Best Poster for the Blood cancer network Meeting on June 9th in in Ireland and the title is “Determining the anti-apoptotic BCL-2 family dependency of T-cell acute lymphoblastic leukaemia in distinct microenvironments”
Phil is a Neurosurgeon in Beaumont Hospital who undertook his PhD under the supervision of Prof. Prehn, Prof. Annette Byrne and Mr. David O’ Brien
His thesis title’ Anti-angiogenic efficacy of Bevacizumab alone in combination with a dual P13K/mTOR inhibitor in an orthotopic model of malignant glioma: A multimodal neuro-imaging approach
The CeBioND consortium is performing a cross disease analysis to investigate common and distinct mechanisms of mitochondrial energetic dysfunction in neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington’s disease. Prof. Jochen Prehn, Dr. Niamh Connolly and Dr. Orla Watters from the Department of Physiology are the RCSI members of the international consortium, which also includes Dr. Maria Ankarcrona and Dr. Catarina Pinho from the Karolinska Institutet in Sweden, Dr. Paola Pizzo and Dr. Pierre Theurey from the University of Padova in Italy, Dr. David Park and Dr. Alvin Joselin from the University of Ottawa in Canada, and Dr. Daniele Bano and Dr. Anna Gioran from the German Center for Neurodegenerative Diseases (DZNE) in Germany.More information on the CeBioND consortium can be found at www.cebiond.org.
Prof. Jochen Prehn talking about the importance of having the brain tumour biobank resource as a means to further understand the disease: see link below for more information
and news article
More information can also be found
See link for pics of the day
Among the speakers were:
Cíara Dunphy (Oral Poster Presentation)
Dr Catríona Dowling (Proffered Paper)
Dr Ian Miller (Irish Cancer Society Fellow Presentation)
Louise Walsh (Irish Cancer Society Scholar Presentation)
Dr Steven Carberry
Dr Manuela Salvucci
Alessandra Di Grande
Here are some pics
Professor Jochen Prehn’s research was a focus on the Sunday Times issue 19-2-17 where he talks about how a molecular test developed at the Royal College of Surgeons in Ireland (RCSI) can predict how bowel cancer will respond to chemotherapy, ensuring that patients for whom the procedure is potentially counterproductive do not need to get the treatment.
BowelScreen, a public screening programme, can help to diagnose bowel cancers earlier than before, according to Jochen Prehn, professor of physiology and medical physics at the RCSI, who led the research team.
The test was developed when RCSI gained access to cancer tissue from 400 patients who were part of two large studies in Ireland, Europe and America of people with bowel cancer.
Tuesday 7th February 2017: 17 transition year students from schools across Dublin are taking part in a three day interactive RCSI (Royal College of Surgeons in Ireland) Mini-Science programme, which is running from 6th – 8th February. As part of the course, students will experience life as a scientific researcher. This programme is being co-ordinated by Dr Helena Bonner in the Department of Physiology and Medical Physics at RCSI, in conjunction with the Centre for Systems Medicine, based at RCSI.
An R package developed for handling naming challenges of mature miRNAs. miRNAmeConverter delivers results in a fast and transparent way. Its main functions are to check for validity of mature miRNA names, to determine the most likely miRBase version of a given set of miRNAs and to translate mature miRNA names to different versions (including sequences). A web interface enables users less familiar with R to translate miRNA names given in form of a list or embedded in text and download of the results.
…an easy way to translate mature miRNA names to different versions.If you make use of the miRNAmeConverter please cite:
Haunsberger SJ, Connolly NMC and Prehn JHM* (2016). “miRNAmeConverter: an R/Bioconductor package for translating mature miRNA names to different miRBase versions.” Bioinformatics. doi: 10.1093/bioinformatics/btw660